Welcome to Grifols. We are an emerging CDMO partner with a focus on producing challenging proteins made in microbial hosts.
Grifols has more than 25 years of experience in recombinant protein technology and we partner with companies interested in developing complex proteins into therapeutics, vaccines, or diagnostics.
We have a cGMP biological manufacturing facility in the San Francisco Bay Area for long-term, high-quality, commercial manufacturing of recombinant biologic drug substance and specializes in recombinant E. coli, yeast and cell culture production.
We are also a provider of Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Hepatitis B Virus (HBV) antigens for immunoassay diagnostics. Whether you want antigens from our current menu or custom proteins, our specialists will partner with you to leverage our core development and manufacturing capabilities to provide high-quality, recombinant proteins for your program.
Visit us at the following shows:
Grifols Recombinant Protein CDMO Services
4560 Horton Street
Emeryville, CA 94608
Contact: Paul Magreta
While the end result of regulatory compliance with quality standards is binary, the processes employed to get there do not need to be rigid, prescriptive, inefficient, and expensive. In fact, updating quality assurance strategies and business practices with a healthy dose of flexibility and innovation can create an important point of differentiation by driving lower costs and higher efficiencies.
Grifols is your biologics CDMO partner with expertise in process development to GMP manufacturing.
Grifols' Consolidated Manufacturing Facility (CMF) is a flexible, multiproduct facility with available manufacturing capacity that created an opportunity to leverage their existing technical expertise and commitment to quality to provide contract services to biopharma companies as a recombinant protein CDMO and support the development of innovative therapies. We recently spoke with Paul Magreta at Grifols about their new $80 million manufacturing facility in Emeryville, California, and the CDMO Services they offer.
Emeryville, CA - Grifols (MCE: GRF, MCE: GRF.P andNASDAQ: GRFS), a global healthcare company with a history of more than 75 years of improving people's health and well-being and a leader in the development of innovative diagnostic solutions, recently received approval from the U.S. Food & Drug Administration to relocate existing immunodiagnostic manufacturing operations to a new Consolidated Manufacturing Facility (CMF) in Emeryville, California
Grifols has manufactured antigens for global diagnostic companies’ use in donor screening and clinical diagnostic assays for more than 25 years. Explore partnering opportunities with Grifols.